Arthex Biotech Announces FDA Rare Pediatric Designation (RPD) Of ATX-01 For The Treatment Of Myotonic Dystrophy Type 1 (DM1)

(MENAFN - PR Newswire) VALENCIA, Spain, Nov. 7, 2024 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through ...

By: menafn